Antipsychotics

Author(s):  
Andrew J. Roth ◽  
Christian J. Nelson

Antipsychotics in a cancer setting are often used with different goals than in a general psychiatric setting. In a cancer population, antipsychotics primarily help manage delirium, confusion, agitation, and manic episodes, but they also treat anxiety, insomnia, and nausea and can improve appetite. The potential causes of delirium are many and variable, and must be identified and addressed. However, antipsychotic medication may be needed to facilitate a medical workup to allow appropriate treatment by helping to manage symptoms such as agitation, hallucinations, delusions, and disorganized thinking. This chapter discusses pearls for recognizing delirium because confusion may start insidiously or quickly, lethargically or turbulently, sometimes from an obvious trigger, and sometimes not, and at times in an outpatient setting. Non-prescribers who understand the features of delirium and appreciate the appropriate use of antipsychotics can help educate and support patients and their families to expedite and promote timely and appropriate treatment for a potentially dangerous entity. Non-prescribing clinicians will learn the indications for use of antipsychotics in cancer care, the reasons prescribers chooses different medications in different situations, and to recognize side effects such as akathisia or restlessness, muscle rigidity, and sedation so they can communicate their observations with prescribers.

2017 ◽  
Author(s):  
Katie Cherenzia

<p>With the evolution of cancer care and chemotherapy agents over the last 15 years there has been an evident shift in care from the inpatient to the ambulatory setting. There is a growing need for cancer care, particularly in the ambulatory (outpatient) setting. Patients receiving chemotherapy in the outpatient setting return home immediately after completing treatment and do not have direct medical and nursing supervision to monitor for and address side effects or adverse reactions of treatment in a hospital inpatient setting. Nurse telephone follow-up post initial chemotherapy allows for assessment and timely management of potential side effects experienced after the administration of chemotherapy in the outpatient setting. The purpose of this quality improvement project was to develop a standardized nurse telephone follow-up procedure post initial chemotherapy. The author developed an electronic script guideline and documentation tool along with a process for conducting the nurse-initiated calls. The project design included an educational activity and a post evaluation of the telephone follow-up procedure. Fifteen biotherapy/chemotherapy nurses participated in a four week pilot. During the four week pilot period 14 out of 34 first time chemotherapy patients received telephone follow-up utilizing the script guidelines. Ten nurses (N=10, 67%) completed the post evaluation survey. Results indicated that overall the script guidelines for telephone follow-up post initial chemotherapy was well received by staff and utilized appropriately. Replication of this project should include examining the impact of telephone follow-up on patient satisfaction and outcomes. The APRN is essential in promoting evidence-based practice and bringing it into the daily practices of staff nurses to improve the quality of care for patients and their families.</p>


2021 ◽  
pp. 1-23
Author(s):  
Muhmmad Saeed ◽  
Muhmmad Ahsan ◽  
Atiqe Ur Rahman ◽  
Muhammad Haris Saeed ◽  
Asad Mehmood

Brain tumors are one of the leading causes of death around the globe. More than 10 million people fall prey to it every year. This paper aims to characterize the discussions related to the diagnosis of tumors with their related problems. After examining the side effects of tumors, it encases similar indications, and it is hard to distinguish the precise type of tumors with their seriousness. Since in practical assessment, the indeterminacy and falsity parts are frequently dismissed, and because of this issue, it is hard to notice the precision in the patient’s progress history and cannot foresee the period of treatment. The Neutrosophic Hypersoft set (NHS) and the NHS mapping with its inverse mapping has been design to overcome this issue since it can deal with the parametric values of such disease in more detail considering the sub-parametric values; and their order and arrangement. These ideas are capable and essential to analyze the issue properly by interfacing it with scientific modeling. This investigation builds up a connection between symptoms and medicines, which diminishes the difficulty of the narrative. A table depending on a fuzzy interval between [0, 1] for the sorts of tumors is constructed. The calculation depends on NHS mapping to adequately recognize the disease and choose the best medication for each patient’s relating sickness. Finally, the generalized NHS mapping is presented, which will encourage a specialist to extricate the patient’s progress history and to foresee the time of treatment till the infection is relieved.


2016 ◽  
pp. 80-84
Author(s):  
Liudmyla Khimion ◽  
Oksana Yashchenko ◽  
Svitlana Danylyuk ◽  
Tetiana Sytyuk

The article considers the mechanism of action, indications for use and analysis of efficiency of using the macrolides, in particular spiramycin, in case of respiratory tract infections in the outpatient setting.


2020 ◽  
Vol 46 (Supplement_1) ◽  
pp. S322-S323
Author(s):  
Dawn Velligan ◽  
Martha Sajatovic

Abstract Background Antipsychotic medications are evidence-based treatments for schizophrenia that improve health outcomes and reduce costs. However, rates of non-adherence to oral antipsychotic medications can exceed 60%. We examined whether a simple checklist to identify individuals not receiving optimum benefit from current oral antipsychotic treatment (NOB Checklist) and The Multi-level Facilitation of Long-acting Antipsychotic Medication Program (MAP) could increase the appropriate use of long-acting injectable antipsychotic medication (LAI) in community clinics. Methods Two clinics in Texas and two in Ohio changed clinical procedures in one of two ways 1) NOB only clinics--providers used a five-item checklist to identify individuals with schizophrenia on oral antipsychotics who were Not receiving Optimum Benefit from current treatment and may therefore benefit from a switch to LAI. 2) MAP- providers used the NOB checklist AND received MAP; MAP is a novel behavior change intervention designed to improve the identification of individuals who could benefit from LAI, improve their outcomes and reduce inappropriate use of resources associated with poor adherence. MAP targets 3 stakeholder groups 1) the consumer for whom peer specialists showed a video describing shared decision making and how to make a choice between tablets and injections, and provided a balanced shared-decision making tool to assist them in choosing medication route,2) the provider who received academic detailing describing various LAI options, how to make good offers as part of a shared decision making dialogue, and important benefits of LAI including the ability to disentangle efficacy versus poor adherence and to help individuals with cognitive and practical problems that lead to poor adherence, and 3) the administrators who received information on how LAI could improve outcomes for individuals and clinic processes, how to encourage the use of LAI among providers and how to provide regular feedback to providers about prescribing practices. The primary outcome was the percentage of LAI versus oral antipsychotic medication prescribed to individuals with schizophrenia. Results Higher NOB checklist scores were associated with an increased provider likelihood of LAI offers and increased consumer acceptance of LAI. All clinics increased use of LAI over time. In Texas, where MAP was fully implemented, the MAP clinic had greater use of LAI over time (eventually reaching about 50% of all antipsychotic use) vs. the NOB only clinic. In Cleveland, the patient stakeholder curriculum was not delivered and there was no significant difference in LAI use between MAP and NOB clinics. Discussion The NOB checklist appears to be a useful tool to help identify patients who might be appropriate candidates for LAI and the full MAP program may help clinicians and consumers to work together to optimize the appropriate use of LAI in outpatient settings. Implementation must be customized for clinics and workflows to determine which parts of the MAP program are practical and appropriate. Participation of consumer stakeholders may be essential to delivery of the MAP Program.


Author(s):  
Tom Burns ◽  
Mike Firn

This chapter focuses mainly on the importance of maintenance antipsychotic medication and mood stabilizers. It examines procedures to support persistence with these drugs and maintain engagement. The techniques for initiating and monitoring clozapine therapy in the community for patients with resistant schizophrenia are outlined. The practical processes for ensuring and conducting regular structured reviews of long-term medication, both to assess progress and to identify side effects, are described in detail. In addition, the judicious use of antidepressants and benzodiazepines is outlined.


2019 ◽  
Vol 20 (2) ◽  
pp. 341 ◽  
Author(s):  
Dik-Lung Ma ◽  
Chun Wu ◽  
Sha-Sha Cheng ◽  
Fu-Wa Lee ◽  
Quan-Bin Han ◽  
...  

Platinum-based drugs have revolutionized cancer care, but are unfortunately associated with various adverse effects. Meanwhile, natural product scaffolds exhibit multifarious bioactivities and serve as an attractive resource for cancer therapy development. Thus, the conjugation of natural product scaffolds to metal complexes becomes an attractive strategy to reduce the severe side effects arising from the use of metal bearing drugs. This review aims to highlight the recent examples of natural product-conjugated metal complexes as cancer therapies with enhanced selectivity and efficacy. We discuss the mechanisms and features of different conjugate complexes and present an outlook and perspective for the future of this field.


Sign in / Sign up

Export Citation Format

Share Document